OUR ADVISORY BOARD

Andrew
Andrew MacIsaac

Andrew MacIsaac is the Director and CEO of Applied Pharmaceutical Innovation (API), an industry-led not-for-profit organization that serves as a catalyst to support the development of life science products and companies. Prior to API, Andrew served as the Assistant Dean at the University of Alberta’s Faculty of Pharmacy and Pharmaceutical Sciences, and held various roles in the Alberta School of Business and UBC Sauder School of Business.

In his spare time Andrew serves on the Edmonton Chamber of Commerce, Policy Committee, the Province of Alberta Research Commercialization Working Group, the Calgary Life Sciences Innovation Hub Steering Committee, the Edmonton Health City Steering Committee, and a number of company boards and advisory groups.

tim
Tim Meagher

Tim is the Medical Director of Munich Re Canada, where amongst other roles he evaluates medical technologies and novel predictors of risk. He is an Associate Professor of Medicine at McGill University and practices general internal medicine at the McGill University Health Centre. He is a graduate of the National University of Ireland, a Fellow of the Royal College of Physicians of Canada, the Royal College of Physicians of Ireland and the American College of Physicians

To keep fit and sane he swims early morning. He also dabbles with classical and flamenco guitar. He is confident that his four grandchildren are the smartest in the world. No contest.

deborah
Deborah Trudeau

Deborah has over 30 years’ experience in strategy, business development, commercial and manufacturing operations. Formerly, she was Senior Vice-President Licensing and International Business at Trudeau Corporation, a privately held company specializing in the design, development, and distribution of its own “Trudeau” branded kitchenware products where she pioneered the development of licensing and strategic partnerships.

Deborah is Vice-Chair of the Board and Chair of the Governance Committee of the Royal Canadian Mint. She also serves on the board of Crescita Therapeutics Inc. (TSX: CTX and OTC US; CRRTF). She is a Director on the Board of Governors at St. Mary’s Hospital and chairs the Advisory Committee of ‘Women Impact Montreal’ Collective Fund. In 2018, Ms. Trudeau became the second Canadian to serve for a two-year term as Global President and Chair of the Board of the International Women’s Forum (“IWF”).

In her spare time, Deborah enjoys traveling, golfing, gardening and skiing.

Powered by Innovasium